Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations: Phase 2 Study (KETO-SLEEP 2)

NCT06687655 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06687655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06687655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations: Phase 2 Study (KETO-SLEEP 2)
Lead sponsor
Johns Hopkins University
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 29, 2025
Completion date
September 15, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea, sleep